ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Theravance Biopharma Inc

Theravance Biopharma Inc (TBPH)

9.28
0.00
(0.00%)
終了 1月3日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
9.28
買値
8.91
売値
9.58
出来高
-
0.00 日の範囲 0.00
7.44 52 週間の範囲 11.71
時価総額
前日終値
9.28
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
187,094
発行済株式数
49,174,296
配当利回り
-
PER
-8.27
1 株当たり利益 (EPS)
-1.12
歳入
57.42M
純利益
-55.19M

Theravance Biopharma Inc について

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the area... Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
George Town, Cym
設立
-
Theravance Biopharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TBPH. The last closing price for Theravance Biopharma was US$9.28. Over the last year, Theravance Biopharma shares have traded in a share price range of US$ 7.44 to US$ 11.71.

Theravance Biopharma currently has 49,174,296 shares in issue. The market capitalisation of Theravance Biopharma is US$456.34 million. Theravance Biopharma has a price to earnings ratio (PE ratio) of -8.27.

TBPH 最新ニュース

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference PR Newswire DUBLIN, Dec. 17, 2024 DUBLIN, Dec. 17, 2024 /PRNewswire/ -- Theravance...

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Nov. 20, 2024 DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.54-5.498981670069.829.919.231313269.42934902CS
4-0.53-5.402650356789.8110.259.231752189.77677884CS
121.1914.70951792348.0910.268.071870949.34364239CS
261.0312.48484848488.2510.427.442742878.79357732CS
52-2.39-20.479862896311.6711.717.443216408.99822778CS
156-1.9-16.994633273711.1813.177.445602679.7997444CS
260-15.05-61.857788738224.3331.546.155269911.91408364CS

TBPH - Frequently Asked Questions (FAQ)

What is the current Theravance Biopharma share price?
The current share price of Theravance Biopharma is US$ 9.28
How many Theravance Biopharma shares are in issue?
Theravance Biopharma has 49,174,296 shares in issue
What is the market cap of Theravance Biopharma?
The market capitalisation of Theravance Biopharma is USD 456.34M
What is the 1 year trading range for Theravance Biopharma share price?
Theravance Biopharma has traded in the range of US$ 7.44 to US$ 11.71 during the past year
What is the PE ratio of Theravance Biopharma?
The price to earnings ratio of Theravance Biopharma is -8.27
What is the cash to sales ratio of Theravance Biopharma?
The cash to sales ratio of Theravance Biopharma is 7.95
What is the reporting currency for Theravance Biopharma?
Theravance Biopharma reports financial results in USD
What is the latest annual turnover for Theravance Biopharma?
The latest annual turnover of Theravance Biopharma is USD 57.42M
What is the latest annual profit for Theravance Biopharma?
The latest annual profit of Theravance Biopharma is USD -55.19M
What is the registered address of Theravance Biopharma?
The registered address for Theravance Biopharma is P.O. BOX 309, UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, KY1-1104
What is the Theravance Biopharma website address?
The website address for Theravance Biopharma is www.theravance.com
Which industry sector does Theravance Biopharma operate in?
Theravance Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 17.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70.4246
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.14
(0.00%)
0
AACGATA Creativity Global
US$ 0.88
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70.4246
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.14
(0.00%)
0
AACGATA Creativity Global
US$ 0.88
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70.4246
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.14
(0.00%)
0
AACGATA Creativity Global
US$ 0.88
(0.00%)
0

TBPH Discussion

投稿を表示